Skip to main content

. 1968 Feb;52(2):111–116. doi: 10.1136/bjo.52.2.111

Retinal vein occlusion. A comparative study of factors affecting the prognosis, including a therapeutic trial of Atromid S in this condition.

D B Clements, J M Elsby, W D Smith

PMCID: PMC506533 PMID: 5642658

111

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

CARSON P., MCDONALD L., PICKARD S., PILKINGTON T., DAVIES B., LOVE F. EFFECT OF ATROMID ON PLATELET STICKINESS. J Atheroscler Res. 1963 Sep-Dec;3:619–622. doi: 10.1016/s0368-1319(63)80044-7. [DOI] [PubMed] [Google Scholar]
Cullen J. F., Ireland J. T., Oliver M. F. A controlled trial of Atromid therapy in exudative diabetic retinopathy. Trans Ophthalmol Soc U K. 1964;84:281–295. [PubMed] [Google Scholar]
Hayreh S. S. Occlusion of the central retinal vessels. Br J Ophthalmol. 1965 Dec;49(12):626–645. doi: 10.1136/bjo.49.12.626. [DOI] [PMC free article] [PubMed] [Google Scholar]
OLIVER M. F. ATROMID-S AND ATROMID. Practitioner. 1964 Mar;192:424–430. [PubMed] [Google Scholar]
Paton A., Rubinstein K., Smith V. H. Arterial insufficiency in retinal venous occlusion (a short symposium). Trans Ophthalmol Soc U K. 1964;84:559–595. [PubMed] [Google Scholar]
VANNAS S., ORMA H. Experience of treating retinal venous occlusion with anticoagulant and antisclerosis therapy. AMA Arch Ophthalmol. 1957 Dec;58(6):812–828. doi: 10.1001/archopht.1957.00940010834004. [DOI] [PubMed] [Google Scholar]

ACTIONS

RESOURCES